Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12

Cancer Research

Volumn 59, Issue 2, 1999, Pages 414-421

  Cavallo, Federica ^a   Di Carlo, Emma ^b   Butera, Monia ^a   Verrua, Roberta ^a   Colombo, Mario P ^c   Musiani, Piero ^b   Forni, Guido ^a,d  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d SAN LUIGI GONZAGA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER ANTIBODY; CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 12; MONOKINE; RECOMBINANT INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST ADENOCARCINOMA; CANCER INHIBITION; CANCER THERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; FEMALE; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATUMORAL DRUG ADMINISTRATION; METASTASIS INHIBITION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR GROWTH; VASCULAR TUMOR;

ANIMALS; ANTIBODIES, NEOPLASM; CYTOKINES; FEMALE; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-12; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NEUTROPHILS; RECOMBINANT PROTEINS; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0033556011     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., and Gately, M. K. Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J. Exp. Med., 178: 1223-1230, 1993.
2. Nastala, C. L., Edington, H. D., McKinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., and Storkus, W. J. Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol., 153: 1697-1706, 1994.
3. Mu, J., Zou, J. P., Yamamoto, N., Tsutsui, T., Tai, K. G., Kobayashi, M., Herrmann, S., Fujiwara, H., and Hamaoka, T. Administration of recombinant IL-12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. Cancer Res., 55: 4404-4408, 1995.
4. Zou, J. P., Yamamoto, N., Fujii, T., Takenaka, H., Kobayashi, M., Herrmann, S. H., Wolf, S. F., Fujiwara, H., and Hamaoka, T. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed interferon-γ production by antitumor T cells. Int. Immunol., 7: 1135-1145, 1995.
5. Noguchi, Y., Jungbluth, A., Richards, E. C., and Old, L. J. Effect of interleukin 12 on tumor induction by 3-methylcholanthrene. Proc. Natl. Acad. Sci. USA, 93: 11798-11801, 1996.
6. Tannenbaum, C. S., Wicker, N., Armstrong, D., Tubbs, R., Finke, J., Bukowski, R., and Hamilton, T. A. Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12. J. Immunol., 156: 693-699, 1996.
7. Hunter, S. E., Waldburger, K. E., Thibodeaux, D. K., Schaub, R. G., Goldman, S. J., and Leonard, J. P. Immunoregulation by interleukin-12 in MB49.1 tumor-bearing mice: cellular and cytokine-mediated effector mechanisms. Eur. J. Immunol., 27: 3438-3446, 1997.
8. Verbik, D. J., Stinson, W. W., Brunda, M. J., Kessinger, A., and Joshi, S. S. In vivo therapeutic effects of interleukin-12 against highly metastatic residual lymphoma. Clin. Exp. Metastasis. 14: 219-229, 1996.
9. Boggio, K., Nicoletti, G., Di Carlo, E., Cavallo, F., Landuzzi, L., Melani, C., Giovarelli, M., Rossi, I., Nanni, P., De Giovanni, C., Bouchard, P., Wolf, S., Modesti, A., Musiani, P., Lollini, P. L., Colombo, M. P., and Forni, G. Interleukin-12 mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J. Exp. Med., 188: 589-596, 1998.
10. Cavallo, F., Signorelli, P., Giovarelli, M., Musiani, P., Modesti, A., Brunda, M. J., Colombo, M. P., and Forni, G. Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. J. Natl. Cancer Inst., 89: 1049-1058, 1997.
11. Tahara, H., Zeh, H., III, Storkus, W. J., Pappo, I., Watkins, S. C., Gubler, U., Wolf, S. F., Robbins, P. D., and Lotze, M. T. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res., 54: 182-189, 1994.
12. Zitvogel, L., Tahara, H., Robbins, P. D., Storkus, W. J., Clarke, M. R., Nalesnik, M. A., and Lotze, M. T. Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. J. Immunol., 155: 1393-1403, 1995.
13. Tahara, H., Zitvogel, L., Storkus, W. J., Zeh, H., III, McKinney, T. G., Schreiber, R. D., Gubler, U., Robbins, P. D., and Lotze, M. T. Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol., 54: 6466-6474, 1995.
14. Vagliani, M., Rodolfo, M., Cavallo, F., Parenza, M., Melani, C., Parmiani, G., Forni, G., and Colombo, M. P. IL-12 potentiates the curative effect of a vaccine based on IL-2-transduced tumor cells. Cancer Res., 56: 467-470, 1996.
15. Meko, J. B., Yim, J. H., Tsung, K., and Norton, J. A. High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine IL-12. Cancer Res., 55: 4765-4770, 1995.
16. Martinotti, A., Stoppacciaro, A., Vagliani, M., Melani, C., Spreafico, F., Wysocka, M., Parmiani, G., Trinchieri, G., and Colombo, M. P. CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. Eur. J. Immunol., 25: 137-146, 1995.
17. Kurzawa, H., Wysocka, M., Aruga, E., Chang, A. E., Trinchieri, G., and Lee, W. M. F. Interleukin 12 enhances cellular immune responses to vaccination only after a period of suppression. Cancer Res., 58: 491-499, 1998.
18. Yu, W. G., Yamamoto, N., Takenaka, J., Mu, J., Tai, X. G., Zou, J. P., Ogawa, M., Tsutsui, T., Wijesuriya, R., Yoshida, R., Herrmann, S., Fujiwara, H., and Hamaoka, T. Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12. Int. Immunol., 8: 855-865, 1996.
19. Fujiwara, H., Zou, J. P., Herrmann, S., and Hamaoka, T. A sequence of cellular and molecular events involved in IL-12-induced tumor regression. Res. Immunol., 146: 636-644, 1995.
20. Fujiwara, H., Clark, S. C., and Hamaoka, T. Cellular and molecular mechanisms underlying IL-12-induced tumor regression. Ann. N. Y. Acad. Sci., 795: 294-309, 1996.
21. Giovarelli, M., Musiani, P., Modesti, A., Dellabona, P., Casorati, G., Allione, A., Consalvo, M., Cavallo, F., Di Pierro, F., De Giovanni, C., Musso, T., and Forni, G. The local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances the antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody dependent immune memory. J. Immunol., 155: 3112-3123, 1995.
22. Nicoletti, G., De Giovanni, C., Lollini, P. L., Bagnara, G. P., Scotlandi, K., Landuzzi, L., Del Re, B., Zauli, G., Prodi, G., and Nanni, P. In vivo and in vitro production of haematopoietic colony-stimulating activity by murine cell lines of different origin: a frequent finding. Eur. J. Cancer Clin. Oncol., 25: 1281-1286, 1989.
23. Di Carlo, E., Coletti, A., Modesti, A., Giovarelli, M., Forni, G., and Musiani, P. Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibit pro- and anti-inflammatory activity and result in a delayed tumor rejection. Eur. Cytokine Netw., 9: 61-68, 1998.
24. Musiani, P., Modesti, A., Giovarelli, M., Cavallo, F., Colombo, M. P., Lollini, P. L., and Forni, G. Cytokines, tumor cell death and immunogenicity: a question of choice. Immunol. Today, 18: 32-36, 1997.
25. Cavallo, F., Di Pierro, F., Giovarelli, M., Gulino, A., Vacca, A., Stoppacciaro, A., Forni, M., Modesti, A., and Forni, G. Protective and curative potential of vaccination with interleukin-2-gene-transfected cells from a spontaneous mouse mammary adenocarcinoma. Cancer Res., 53: 5067-5070, 1993.
26. Trinchieri, G. Proinflammatory and immunoregulatory functions of interleukin-12. Int. Rev. Immunol., 16: 365-396, 1998.
27. Mantovani, A. Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines. Lab. Investig., 71: 5-16, 1994.
28. Lollini, P. L., Bosco, M. C., Cavallo, F., De Giovanni, C., Giovarelli, M., Landuzzi, L., Musiani, P., Modesti, A., Nicoletti, G., Palmieri, G., Santoni, A., Young, H. A., Forni, G., and Nanni, P. Inhibition of tumor growth and enhancement of metastasis after transfection of the γ-interferon gene. Int. J. Cancer. 55: 320-329, 1993.
29. Coughlin, C. M., Sajhany, K. E., Gee, M. S., LaTemple, D. C., Kotenko, S., Ma, X., Gri, G., Wysocka, M., Kim, J. E., Farber, J. M., Pestka, S., Trinchieri, G., and Lee, W. M. F. Tumor cell responses to IFN-γ affect tumorigenicity and response to IL-12 therapy and antiangiogenesis. Immunity, 9: 25-34, 1998.
30. Teruya-Feldstein, J., Jaffe, E. S., Burd, P. R., Kanegane, H., Kingma, D. W., Wilson, W. L., Longo, D. L., and Tosato, G. The role of Mig, the monokine induced by interferon-γ, and IP-10, the interferon-γ-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative diseases. Blood, 90: 4099-4110, 1997.
31. Sgadari, C. Angiolillo, A. L., and Tosato, G. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood, 87: 3877-3882, 1996.
32. Pipili-Synetos, E., Papageorgiou, A., Sakkoula, E., Sotiropoulou, G., Fotsis, T., Karakiulakis, G., and Maragoudakis, M. E. Inhibition of angiogenesis, tumor growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br. J. Pharmacol., 116: 1829-1834, 1995.
33. Wigginton, J. M., Kuhns, B. D., Back, T. C., Brunda, M. J., Wiltrout, R. H., and Cox, G. W. Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: implications for the antitumor activity of interleukin 12 and/or interleukin 2. Cancer Res., 56: 1131-1136, 1996.
34. 3 in the disruption of the tumor vasculature induced by TNF and IFN-γ. Nat. Med., 4: 408-414, 1998.
35. Coughlin, C. M. Salhany, K. E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A. E., Hunter, C. A., Fox, J. C. Trinchieri, G., and Lee, W. M. F. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Investig., 101: 1441-1452, 1998.
36. Colombo, M. P., Lombardi, L., Melani, C., Parenza, M., Baroni, C., Ruco, L., and Stoppacciaro, A. Hypoxic tumor cell death and modulation of endothelial adhesion molecules in the regression of granulocyte colony-stimulating factor-transduced tumors. Am. J. Pathol., 148: 473-483, 1996.
37. Ogawa, M., Tsutsui, T., Zou, J. P., Mu, J., Wijesuriya, R., You, W. G., Herrmann, S., Kubo, T., Fujiwara, H., and Hamaoka, T. Enhanced induction of very late antigen 4/lymphocyte function-associated antigen 1-dependent T-cell migration to tumor sites following administration of interleukin-12. Cancer Res., 57: 2216-2222, 1997.
38. Taub, D. D., Lloyd, A. R., Conlon, K., Wang, J. M., Ortaldo, J. R., Harada, A., Matsushima, K., Kevlin, D. J., and Oppenheim, J. J. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J. Exp. Med., 177: 1809-1814, 1993.
39. Mantovani, A., Bar Shavit, Z., Peri, G., Polentarutti, N., Bordignon, C., Sessa, C., and Mangioni, C. Natural cytotoxicity on tumor cells of human macrophages obtained from diverse anatomical sites. Clin. Exp. Immunol., 39: 776-784, 1980.
40. Weslin, W. F., and Gimbrone, J. R. Neutrophil-mediated damage to human vascular endothelium. Am. J. Pathol., 142: 117-128, 1993.
41. Varesio, L., Giovarelli, M., Landolfo, S., and Forni, G. Suppression of proliferative response and lymphokine release during the progression of a spontaneous tumor. Cancer Res., 39: 4983-4990, 1979.
42. Houghton, A. H., and Lloyd, K. O. Stuck in the MUC on the long and winding road. Nat. Med., 4: 270-271, 1998.